87 | Humans |
51 | Animals |
33 | Coronavirus |
29 | Human |
25 | Severe acute respiratory syndrome |
20 | SARS Virus (genetics) |
18 | Severe Acute Respiratory Syndrome (virology) |
17 | Severe Acute Respiratory Syndrome (epidemiology) |
17 | Molecular Sequence Data |
16 | Amino Acid Sequence |
15 | SARS Virus (metabolism) |
14 | Disease Outbreaks |
13 | Male |
12 | Viral Nonstructural Proteins (metabolism) |
12 | Spike Glycoprotein, Coronavirus |
12 | SARS Virus (pathogenicity) |
11 | Severe Acute Respiratory Syndrome (transmission) |
11 | Female |
11 | Coronavirus (genetics) |
11 | COVID-19 |
10 | Virus Replication |
10 | Viral disease |
10 | Viral Nonstructural Proteins (genetics) |
10 | Phylogeny |
10 | Microbiology |
10 | Emerging disease |
10 | Coronavirus Infections (virology) |
10 | Coronavirus Infections (epidemiology) |
10 | Adult |
9 | Virus |
9 | SARS-CoV-2 |
9 | SARS Virus |
9 | Public health |
9 | Influenza, Human (epidemiology) |
9 | China (epidemiology) |
9 | Betacoronavirus |
9 | Antiviral |
8 | Viral Nonstructural Proteins (chemistry) |
8 | SARS Virus (immunology) |
8 | SARS Virus (chemistry) |
8 | Pneumonia |
8 | Models, Molecular |
8 | Middle Aged |
8 | France |
8 | Epidemiology |
8 | Coronavirus Infections (transmission) |
8 | Communicable Diseases, Emerging (epidemiology) |
8 | Cell Line |
7 | Zoonosis |
7 | Virus Diseases (epidemiology) |
7 | Virology |
7 | Viral Proteins (metabolism) |
7 | Viral Envelope Proteins (metabolism) |
7 | Viral Envelope Proteins (chemistry) |
7 | Severe Acute Respiratory Syndrome (immunology) |
7 | Severe Acute Respiratory Syndrome (diagnosis) |
7 | SARS Virus (physiology) |
7 | SARS Virus (isolation & purification) |
7 | Review |
7 | RNA, Viral (genetics) |
7 | Protein Binding |
7 | Membrane Glycoproteins (metabolism) |
7 | Infection |
7 | Genome, Viral |
7 | Coronavirus Infections (diagnosis) |
7 | Chiroptera (virology) |
7 | Child |
7 | Base Sequence |
7 | Antiviral Agents (pharmacology) |
6 | Virus Diseases (transmission) |
6 | Viral Proteins (genetics) |
6 | Vero Cells |
6 | Severe Acute Respiratory Syndrome (prevention & control) |
6 | RNA Replicase (genetics) |
6 | RNA Replicase (chemistry) |
6 | Pneumonia, Viral (epidemiology) |
6 | Models, Biological |
6 | Mice |
6 | Methyltransferases (metabolism) |
6 | Membrane Glycoproteins (chemistry) |
6 | Influenza |
6 | Global Health |
6 | Exoribonucleases (metabolism) |
6 | Epidemic |
6 | Coronavirus Infections (veterinary) |
6 | Coronavirus (classification) |
6 | Communicable Diseases, Emerging (virology) |
6 | Chlorocebus aethiops |
6 | Antibodies, Viral (immunology) |
5 | coronavirus |
5 | Young Adult |
5 | Travel |
5 | Swine |
5 | Sequence Homology, Amino Acid |
5 | SARS Virus (enzymology) |
5 | Risk Factors |
5 | RNA, Viral (metabolism) |
5 | RNA Replicase (metabolism) |
5 | Protein |
5 | Protein Conformation |
5 | Pandemics |
5 | Influenza, Human (transmission) |
5 | Exoribonucleases (genetics) |
5 | Crystallography, X-Ray |
5 | Communicable Diseases, Emerging (prevention & control) |
5 | Child, Preschool |
5 | Adolescent |
4 | Zoonoses (epidemiology) |
4 | Viruses (classification) |
4 | Virus Internalization |
4 | Virus Diseases (prevention & control) |
4 | Viral Vaccines (immunology) |
4 | Viral Envelope Proteins (genetics) |
4 | Veterinary |
4 | Treatment |
4 | Surveillance |
4 | Severe acute respiratory syndrome virus |
4 | Risk factor |
4 | Respiratory tract |
4 | Respiratory disease |
4 | Receptors, Virus (metabolism) |
4 | Real-Time Polymerase Chain Reaction |
4 | RNA, Viral (biosynthesis) |
4 | Protein Structure, Tertiary |
4 | Polymerase Chain Reaction |
4 | Nosocomial infection |
4 | Neutralization Tests |
4 | Mutation (genetics) |
4 | Methyltransferases (genetics) |
4 | Medicine |
4 | Hong Kong (epidemiology) |
4 | Hemorrhagic fever |
4 | Genetic Variation |
4 | Evolution |
4 | Crystallization |
4 | Coronavirus Infections |
4 | Coronavirus Infections (prevention & control) |
4 | Coronavirus (isolation & purification) |
4 | Communicable Diseases, Emerging (transmission) |
4 | Cloning, Molecular |
4 | Chiroptera |
4 | Betacoronavirus (isolation & purification) |
4 | Avian influenza |
4 | Aged |
3 | Zoonoses (virology) |
3 | World |
3 | World Health Organization |
3 | West Nile virus |
3 | Viruses (isolation & purification) |
3 | Virulence |
3 | Viral Proteins (chemistry) |
3 | Viral Nonstructural Proteins (isolation & purification) |
3 | Viral Envelope Proteins (immunology) |
3 | Transmission |
3 | Transmissible gastroenteritis virus (genetics) |
3 | Transfusion |
3 | Transfection |
3 | Structure-Activity Relationship |
3 | Structure activity relation |
3 | Severe Acute Respiratory Syndrome (therapy) |
3 | SARS Virus (growth & development) |
3 | SARS Virus (drug effects) |
3 | SARS Virus (classification) |
3 | SAR |
3 | Reverse Transcriptase Polymerase Chain Reaction |
3 | Respiratory system |
3 | Recombinant Proteins (metabolism) |
3 | Recombinant Proteins (isolation & purification) |
3 | Recombinant Proteins (biosynthesis) |
3 | RNA, Viral (chemistry) |
3 | RNA Replicase (isolation & purification) |
3 | RNA Replicase (antagonists & inhibitors) |
3 | Public Health |
3 | Prevention |
3 | Population Surveillance |
3 | Pneumonia, Viral (transmission) |
3 | Pneumonia, Viral (diagnosis) |
3 | Plasmodium falciparum |
3 | Pathogenic |
3 | Pandemics (prevention & control) |
3 | Mutation |
3 | Models, Statistical |
3 | Mice, Inbred BALB C |
3 | Methyltransferases (chemistry) |
3 | Membrane Glycoproteins (immunology) |
3 | Membrane Fusion (physiology) |
3 | Influenza, Human (virology) |
3 | Infant |
3 | In vitro |
3 | Host-Pathogen Interactions |
3 | Hemorrhagic Fever, Ebola (epidemiology) |
3 | HIV-1 (drug effects) |
3 | Genetic Vectors (genetics) |
3 | Evolution, Molecular |
3 | Enzyme |
3 | Disease Reservoirs (virology) |
3 | Detection |
3 | Coronavirus Infections (drug therapy) |
3 | Coronavirus (metabolism) |
3 | Computer Simulation |
3 | Communicable Diseases, Emerging |
3 | China |
3 | Chikungunya virus |
3 | Bioterrorism |
3 | Binding Sites |
3 | Betacoronavirus (genetics) |
3 | Asia |
3 | Antiviral Agents (chemistry) |
3 | Antibodies, Viral (blood) |
3 | Acute |
3 | AIDS |
2 | virtual screening |
2 | tagging |
2 | surveillance network |
2 | proofreading |
2 | positive fragmentation |
2 | pandemic |
2 | outbreak |
2 | otolith microchemistry |
2 | nursery |
2 | molecular epidemiology |
2 | models |
2 | indicator |
2 | grid |
2 | epidemiology |
2 | diversity |
2 | curves |
2 | connectivity |
2 | biodiversity |
2 | artificial habitats |
2 | Zoonoses |
2 | X-Ray Diffraction |
2 | Wild animal |
2 | West Nile Fever (epidemiology) |
2 | Viruses |
2 | Viruses (immunology) |
2 | Viruses (genetics) |
2 | Virus replication cycle |
2 | Virus Replication (drug effects) |
2 | Virus Assembly |
2 | Virology (methods) |
2 | Viral Vaccines (genetics) |
2 | Viral Vaccines (administration & dosage) |
2 | Viral Nonstructural Proteins (antagonists & inhibitors) |
2 | Viral Matrix Proteins (metabolism) |
2 | Viral Envelope Proteins (physiology) |
2 | Viral Envelope Proteins (biosynthesis) |
2 | Viral Envelope Proteins (analysis) |
2 | Vaccine |
2 | Tropical medicine |
2 | Transcription |
2 | Time Factors |
2 | Thailand |
2 | Technology |
2 | Stochastic Processes |
2 | Standard |
2 | Severe Acute Respiratory Syndrome |
2 | Severe Acute Respiratory Syndrome (pathology) |
2 | Sequence Analysis, DNA |
2 | Sequence Alignment |
2 | Sentinel Surveillance |
2 | Seasons |
2 | Sanitary surveillance |
2 | SARs |
2 | SARS-CoV |
2 | SARS epidemic |
2 | Risk |
2 | Risk Assessment |
2 | Respiratory system infection |
2 | Respiratory distress |
2 | Reservoir |
2 | Replication |
2 | Recombination, Genetic |
2 | Recombinant Proteins (chemistry) |
2 | Receptors, Virus (genetics) |
2 | Rabbits |
2 | RNA, Viral (analysis) |
2 | RNA virus |
2 | RNA Viruses (genetics) |
2 | RNA Helicases (metabolism) |
2 | RNA Caps (metabolism) |
2 | RNA (metabolism) |
2 | Quinolines (pharmacology) |
2 | Quinolines (chemistry) |
2 | Quinolines (chemical synthesis) |
2 | Protein Interaction Maps |
2 | Protein Domains |
2 | Pregnancy |
2 | Pneumopathy |
2 | Pneumonia, Viral (virology) |
2 | Pneumonia, Viral (prevention & control) |
2 | Peptide Fragments (chemistry) |
2 | Patient Isolation |
2 | Oxidation-Reduction |
2 | Nucleocapsid Proteins (immunology) |
2 | Nucleocapsid Proteins (genetics) |
2 | Non-linear microscopy |
2 | Nereis virens |
2 | Mutagenesis |
2 | Molecular epidemiology |
2 | Molecular biology |
2 | Molecular Epidemiology |
2 | Middle East Respiratory Syndrome Coronavirus |
2 | Middle East Respiratory Syndrome Coronavirus (isolation & purification) |
2 | Middle East Respiratory Syndrome Coronavirus (immunology) |
2 | Microorganism |
2 | Methyltransferases (antagonists & inhibitors) |
2 | Membrane Glycoproteins (physiology) |
2 | Membrane Glycoproteins (genetics) |
2 | Membrane Glycoproteins (biosynthesis) |
2 | Measles Vaccine (immunology) |
2 | Measles Vaccine (genetics) |
2 | MERS-CoV |
2 | International Cooperation |
2 | Influenzavirus |
2 | Influenza, Human (diagnosis) |
2 | Influenza in Birds (epidemiology) |
2 | Influenza A Virus, H5N1 Subtype |
2 | Influenza A Virus, H5N1 Subtype (pathogenicity) |
2 | Infant, Newborn |
2 | Immunity, Innate |
2 | Identification |
2 | HepG2 cytotoxicity |
2 | Health hazards |
2 | HEK293 Cells |
2 | Genotype |
2 | Genetics |
2 | Gene Expression Regulation, Viral |
2 | France (epidemiology) |
2 | Exoribonucleases (chemistry) |
2 | Europe (epidemiology) |
2 | Enzyme inhibitor |
2 | Enteritis |
2 | Emergence |
2 | Drug Design |
2 | Disease Transmission, Infectious (prevention & control) |
2 | Discussion |
2 | Digital holography |
2 | Diagnosis |
2 | DNA, Viral (analysis) |
2 | Cysteine endopeptidases |
2 | Crystallography |
2 | Cross Infection (virology) |
2 | Cross Infection (transmission) |
2 | Cross Infection (epidemiology) |
2 | Coronavirus Infections (immunology) |
2 | Coronavirus (ultrastructure) |
2 | Coronavirus (physiology) |
2 | Coronavirus (pathogenicity) |
2 | Coronavirus (immunology) |
2 | Coronavirus (enzymology) |
2 | Coronavirus (drug effects) |
2 | Computational Biology |
2 | Clinical form |
2 | Climate |
2 | Chloroquine |
2 | Chemical synthesis |
2 | Cattle |
2 | Catalytic Domain |
2 | Cambodia |
2 | Brain (virology) |
2 | Birds |
2 | Bioturbation |
2 | Binding mode |
2 | Betacoronavirus (classification) |
2 | Bacteriosis |
2 | Asia (epidemiology) |
2 | Antibody Formation |
2 | Antibodies, Neutralizing (immunology) |
2 | Antibodies, Monoclonal |
2 | Anti-HIV Agents (pharmacology) |
2 | Anti-HIV Agents (chemical synthesis) |
2 | Alphavirus Infections (epidemiology) |
2 | Alphacoronavirus (isolation & purification) |
2 | Alphacoronavirus (genetics) |
2 | Alphacoronavirus (classification) |
2 | Algorithms |
2 | Aged, 80 and over |
2 | 2019-nCoV |
2 | SARs |
1 | zebrafish |
1 | writing aid |
1 | wildlife |
1 | wild rabbits |
1 | virus replication |
1 | urea |
1 | terminology |
1 | term extraction |
1 | telemedicine |
1 | telehealth |
1 | technical writing |
1 | taxonomic harmonisation |
1 | tRNA Methyltransferases |
1 | surveillance |
1 | surréalisme |
1 | structure-activity relationships |
1 | ssRNA viruses |
1 | species-area relationship |
1 | specialized vocabulary |
1 | specialized language |
1 | spatial distribution |
1 | socioeconomic status |
1 | scientific writing |
1 | sARS-CoV-2 |
1 | rodents |
1 | richness |
1 | ribavirin |
1 | respiratory mortality |
1 | regulatory knowledge |
1 | regulation |
1 | random walk |
1 | questionnaires |
1 | public health |
1 | prediction |
1 | pollution |
1 | plant diversity |
1 | patterns |
1 | particulate matter |
1 | pareto optimization |
1 | one-fifth success rule |
1 | one plus one |
1 | non-structural protein 14 |
1 | nidovirus |
1 | modelling |
1 | medaka |
1 | mapping |
1 | m-RT-PCR-ELISA |
1 | logistic-regression |
1 | linear convergence |
1 | language for specific purposes |
1 | islands |
1 | island biogeography |
1 | irradiation |
1 | interactive |
1 | information systems |
1 | influenza |
1 | influenza-like illness |
1 | industrial chemicals |
1 | indexHabitat specialization |
1 | immunology |
1 | hedgehogs |
1 | germline chimeras |
1 | genetic diversity |
1 | gastrulation |
1 | function-value-free optimization |
1 | formamide |
1 | fold evolution |
1 | fish |
1 | farmland bird |
1 | exoribonuclease |
1 | evolution strategy |
1 | epidemic modeling |
1 | environmental protection agency |
1 | environment |
1 | endoderm |
1 | emergency preparedness |
1 | embryo |
1 | diversity-area relationship |
1 | distributions |
1 | dispersal |
1 | disease outbreaks |
1 | disasters |
1 | disaster planning |
1 | digital medicine |
1 | digital health |
1 | derivative-free optimization |
1 | data collection |
1 | correspondance |
1 | coronaviruses |
1 | controlled language |
1 | containment |
1 | contact tracing |
1 | comparison-based |
1 | climate-change |
1 | cell transplantation |
1 | cell migration |
1 | casanova |
1 | bats |
1 | bHLH |
1 | avian flu |
1 | avant-gardes |
1 | antiviral agents |
1 | antiplasmodial activity |
1 | agricultural intensity |
1 | agri-environment schemes |
1 | agri-environment scheme |
1 | accumulation |
1 | Zoonoses (transmission) |
1 | Zoonoses (prevention & control) |
1 | Zoonoses (etiology) |
1 | Zimbabwe |
1 | Zika Virus Infection |
1 | Zika Virus Infection (transmission) |
1 | Zika Virus Infection (prevention & control) |
1 | Zika Virus Infection (epidemiology) |
1 | Zika Virus Infection (diagnosis) |
1 | ZOOPLANKTON |
1 | X-Ray |
1 | X-BAND |
1 | West Nile Fever (transmission) |